MedTrace Logo

Impact of Etomidate vs. Propofol on Infectious Complications Post Cardiac Surgery

NCT04281706 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1495

Last updated 2023-09-08

No results posted yet for this study

Summary

The aim of this retrospective before-after-study is to evaluate the potential association of etomidate vs. propofol as an induction agent for major cardiac surgery on infectious post-operative complications.

The investigators hypothesize that etomidate increases the rate post-operative infectious complications in cardiosurgical patients.

Conditions

  • Postoperative Complications

Interventions

DRUG

Etomidate vs Propofol as induction agent

Patients undergoing cardiac surgery were induced with Etomidate according to the standard operating procedure for induction until October 1st, 2013, afterwards a new SOP with Propofol as primary induction agent was introduced. After a washout period of 3 months, Propofol was used as sole induction agent. The rest of the standard operating procedure remained the same.

Sponsors & Collaborators

  • Charite University, Berlin, Germany

    lead OTHER

Principal Investigators

  • Prof. Dr. Dr. Felix Balzer, MSc · Charite University, Berlin, Germany

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-15
Primary Completion
2021-01-01
Completion
2021-01-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04281706 on ClinicalTrials.gov